{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:37Z","timestamp":1791639577152,"version":"4.3.4"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Regional Health Authorities of Western Norway","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To map inflammatory biomarkers in patients with autonomous cortisol secretion (ACS) and overt Cushing syndrome (CS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Observational study including serum from prospectively included patients with ACS (n = 63), adrenal CS (n = 2), pituitary CS (n = 8), and healthy subjects (n = 120). Serum samples were analysed for 92 inflammatory biomarkers using proximity extension assay (OLINK).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Combined, the ACS and CS patients displayed significant differences in levels of 49\/92 inflammatory biomarkers (46 increased\/3 decreased) compared with healthy controls. No differences in biomarker levels were found between ACS and overt CS, and none of the biomarkers correlated with the degree of hypercortisolism. Postoperative samples were available for 17 patients, median 24 months (range 6\u201340) after surgery and biochemical curation. There was no significant normalization of the biomarkers postoperatively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There was a systemic rise in inflammatory biomarkers in patients with ACS and CS, not correlated to the degree of hypercortisolism. These biomarkers were not normalized following biochemical cure.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ejendo\/lvad076","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T13:06:28Z","timestamp":1688735188000},"page":"78-86","source":"Crossref","is-referenced-by-count":7,"title":["Substantial changes in inflammatory and cardiovascular biomarkers in patients with autonomous cortisol secretion"],"prefix":"10.1093","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-7689","authenticated-orcid":false,"given":"Grethe \u00c5","family":"Ueland","sequence":"first","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , Jonas Lies vei 65, Bergen 5021 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paal","family":"Methlie","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , Jonas Lies vei 65, Bergen 5021 , Norway"},{"name":"Department of Clinical Science, University of Bergen , Haukelandsveien 9, Bergen 5009 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Heie","sequence":"additional","affiliation":[{"name":"Department of Surgery, Haukeland University Hospital , Jonas Liesvei 65, Bergen 5021 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4496-615X","authenticated-orcid":false,"given":"Ann-Elin","family":"Meling Stokland","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen , Haukelandsveien 9, Bergen 5009 , Norway"},{"name":"Department of Medicine, Stavanger University Hospital , Gerd-Ragna Bloch Thorsens gate 8, Stavanger 4019 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lise","family":"Dahle","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haugesund Hospital , Karmsundgata 120, 5528 Haugesund , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se B","family":"S\u00e6vik","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, University of Bergen , Haukelandsveien 9, Bergen 5009 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"L\u00f8v\u00e5s","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , Jonas Lies vei 65, Bergen 5021 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eystein S","family":"Husebye","sequence":"additional","affiliation":[{"name":"Department of Medicine, Haukeland University Hospital , Jonas Lies vei 65, Bergen 5021 , Norway"},{"name":"Department of Clinical Science, University of Bergen , Haukelandsveien 9, Bergen 5009 , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"issue":"4","key":"2023072108335661300_lvad076-B1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023072108335661300_lvad076-B2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann Intern Med."},{"issue":"2","key":"2023072108335661300_lvad076-B3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev."},{"issue":"2","key":"2023072108335661300_lvad076-B4","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023072108335661300_lvad076-B5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J Endocrinol Invest."},{"issue":"3","key":"2023072108335661300_lvad076-B6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023072108335661300_lvad076-B7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2265.2011.04253.x","article-title":"Subclinical Cushing\u2019s syndrome: definition and management","volume":"76","author":"Terzolo","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2023072108335661300_lvad076-B8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"2","key":"2023072108335661300_lvad076-B9","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023072108335661300_lvad076-B10","doi-asserted-by":"crossref","first-page":"e130-e9","DOI":"10.1210\/clinem\/dgaa695","article-title":"Mental health in patients with adrenal incidentalomas: is there a relation with different degrees of cortisol secretion?","volume":"106","author":"Morelli","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2023072108335661300_lvad076-B11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2023072108335661300_lvad076-B12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0000000000000153","article-title":"Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes","volume":"22","author":"Di Dalmazi","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"1","key":"2023072108335661300_lvad076-B13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12020-012-9622-2","article-title":"Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from southern Sweden","volume":"42","author":"Olsen","year":"2012","journal-title":"Endocrine"},{"issue":"5","key":"2023072108335661300_lvad076-B14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2265.2008.03492.x","article-title":"Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study","volume":"70","author":"Vassilatou","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2023072108335661300_lvad076-B15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","article-title":"Adrenal incidentaloma: a new cause of the metabolic syndrome?","volume":"87","author":"Terzolo","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2023072108335661300_lvad076-B16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12020-020-02297-2","article-title":"Cardiovascular and metabolic risk factors in patients with subclinical Cushing","volume":"70","author":"Petramala","year":"2020","journal-title":"Endocrine"},{"issue":"8","key":"2023072108335661300_lvad076-B17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7326\/M20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: a cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med."},{"issue":"7","key":"2023072108335661300_lvad076-B18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2023072108335661300_lvad076-B19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study","volume":"166","author":"Di Dalmazi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023072108335661300_lvad076-B20","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2023072108335661300_lvad076-B21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing\u2019s syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"issue":"3","key":"2023072108335661300_lvad076-B22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg."},{"issue":"4","key":"2023072108335661300_lvad076-B23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1507\/endocrj.K07E-177","article-title":"Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing\u2019s syndrome","volume":"55","author":"Tsuiki","year":"2008","journal-title":"Endocr J."},{"issue":"9","key":"2023072108335661300_lvad076-B24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00268-005-0681-x","article-title":"Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery","volume":"30","author":"Erbil","year":"2006","journal-title":"World J Surg."},{"issue":"4","key":"2023072108335661300_lvad076-B25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0957","article-title":"Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas","volume":"162","author":"Giordano","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023072108335661300_lvad076-B26","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2018-02552","article-title":"Active Cushing disease is characterized by increased adipose tissue macrophage presence","volume":"104","author":"Lee","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2023072108335661300_lvad076-B27","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing\u2019s syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2023072108335661300_lvad076-B28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2265.2007.02774.x","article-title":"Increased insulin-stimulated endothelin-1 release is a distinct vascular phenotype distinguishing Cushing\u2019s disease from metabolic syndrome","volume":"66","author":"Setola","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2023072108335661300_lvad076-B29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cen.13230","article-title":"Proinflammatory cytokines remain elevated despite long-term remission in Cushing\u2019s disease: a prospective study","volume":"86","author":"Shah","year":"2017","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2023072108335661300_lvad076-B30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2023072108335661300_lvad076-B31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2023072108335661300_lvad076-B32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EC-13-0023","article-title":"Multisteroid LC-MS\/MS assay for glucocorticoids and androgens, and its application in Addison\u2019s disease","volume":"2","author":"Methlie","year":"2013","journal-title":"Endocr Connect."},{"issue":"4","key":"2023072108335661300_lvad076-B33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2023072108335661300_lvad076-B34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/clinchem\/17.4.275","article-title":"Influence of statistical method used on the resulting estimate of normal range","volume":"17","author":"Reed","year":"1971","journal-title":"Clin Chem."},{"issue":"2","key":"2023072108335661300_lvad076-B35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/clinchem\/36.2.265","article-title":"On dividing reference data into subgroups to produce separate reference ranges","volume":"36","author":"Harris","year":"1990","journal-title":"Clin Chem."},{"issue":"4","key":"2023072108335661300_lvad076-B36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2023072108335661300_lvad076-B37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"2023072108335661300_lvad076-B38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40618-017-0644-8","article-title":"First-line screening tests for Cushing\u2019s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS\/MS","volume":"40","author":"Ceccato","year":"2017","journal-title":"J Endocrinol Invest."},{"issue":"9","key":"2023072108335661300_lvad076-B39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1055\/s-0043-115008","article-title":"Body composition is different after surgical or pharmacological remission of Cushing's syndrome: a prospective DXA study","volume":"49","author":"Ceccato","year":"2017","journal-title":"Horm Metab Res"},{"issue":"3","key":"2023072108335661300_lvad076-B40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrcardio.2016.185","article-title":"Inflammatory processes in cardiovascular disease: a route to targeted therapies","volume":"14","author":"Ruparelia","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2023072108335661300_lvad076-B41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2011.02.034","article-title":"Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently","volume":"93","author":"Li","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2023072108335661300_lvad076-B42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4183\/aeb.2016.257","article-title":"Serum levels of fibroblast growth factor 21 in type 2 diabetic patients","volume":"12","author":"Panahi","year":"2016","journal-title":"Acta Endocrinol (Bucharest)"},{"issue":"4","key":"2023072108335661300_lvad076-B43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800.2011.558550","article-title":"Serum FGF-21 levels in type 2 diabetic patients","volume":"36","author":"Cheng","year":"2011","journal-title":"Endocr Res"},{"issue":"6","key":"2023072108335661300_lvad076-B44","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest."},{"issue":"4","key":"2023072108335661300_lvad076-B45","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"2023072108335661300_lvad076-B46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141394","article-title":"Left ventricular dysfunction and CXCR3 ligands in hypertension: from animal experiments to a population-based pilot study","volume":"10","author":"Altara","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2023072108335661300_lvad076-B47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12265-016-9703-3","article-title":"CXCL10 is a circulating inflammatory marker in patients with advanced heart failure: a pilot study","volume":"9","author":"Altara","year":"2016","journal-title":"J Cardiovasc Transl Res"},{"issue":"2","key":"2023072108335661300_lvad076-B48","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ijcard.2012.11.052","article-title":"A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure","volume":"168","author":"Richter","year":"2013","journal-title":"Int J Cardiol."},{"issue":"1","key":"2023072108335661300_lvad076-B49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12933-022-01626-1","article-title":"CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease","volume":"21","author":"Chang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2023072108335661300_lvad076-B50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00011-011-0350-5","article-title":"Potential involvement of CCL23 in atherosclerotic lesion formation\/progression by the enhancement of chemotaxis, adhesion molecule expression, and MMP-2 release from monocytes","volume":"60","author":"Kim","year":"2011","journal-title":"Inflamm Res"},{"issue":"3","key":"2023072108335661300_lvad076-B51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","article-title":"Normal bone mineral density following cure of Cushing\u2019s syndrome","volume":"36","author":"Manning","year":"1992","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2023072108335661300_lvad076-B52","first-page":"1863","article-title":"Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing\u2019s syndrome","volume":"83","author":"Chiodini","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2023072108335661300_lvad076-B53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1530\/eje.0.1410126","article-title":"Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing\u2019s syndrome","volume":"141","author":"Godang","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2023072108335661300_lvad076-B54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.0.1460389","article-title":"Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing\u2019s syndrome","volume":"146","author":"Kristo","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2023072108335661300_lvad076-B55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-09-0800","article-title":"Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome","volume":"162","author":"Camozzi","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2023072108335661300_lvad076-B56","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2017-01324","article-title":"Visceral fat and novel biomarkers of cardiovascular disease in patients with Addison\u2019s disease: a case-control study","volume":"102","author":"Bergthorsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2023072108335661300_lvad076-B57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00005-015-0357-7","article-title":"Inflammatory markers change with age, but do not fall beyond reported normal ranges","volume":"64","author":"Wyczalkowska-Tomasik","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"key":"2023072108335661300_lvad076-B58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/JIR.S294368","article-title":"Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort","volume":"14","author":"Cohen","year":"2021","journal-title":"J Inflamm Res"},{"issue":"2","key":"2023072108335661300_lvad076-B59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.jhh.1001785","article-title":"Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension","volume":"19","author":"Bautista","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2023072108335661300_lvad076-B60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2840-13-34","article-title":"Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of LDL subfraction phenotype","volume":"13","author":"Vinagre","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2023072108335661300_lvad076-B61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbi.2006.11.006","article-title":"An inflammatory review of glucocorticoid actions in the CNS","volume":"21","author":"Sorrells","year":"2007","journal-title":"Brain Behav Immun"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvad076\/50842004\/lvad076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/1\/78\/50921331\/lvad076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/189\/1\/78\/50921331\/lvad076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T16:50:49Z","timestamp":1702745449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/189\/1\/78\/7221520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvad076","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,7]]}}}